LobbyingOrchard Therapeutics North America lobbying by quarter
Orchard Therapeutics North America's latest lobbying report covers Q2 2026, at $310K. The four quarters Q4 2025–Q3 2026 total $1.4M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Orchard Therapeutics North America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.4M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 2 |
| Q1 2023 | $80K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 2 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $110K | 2 |
| Q4 2024 | $210K | 3 |
| Q1 2025 | $380K | 3 |
| Q2 2025 | $580K | 5 |
| Q3 2025 | $370K | 5 |
| Q4 2025 | $440K | 5 |
| Q1 2026 | $600K | 5 |
| Q2 2026 | $310K | 5 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.7M · 33 reports
- Medicare and Medicaid$1.2M · 16 reports
- Budget and appropriations$385K · 15 reports
- Medical research and clinical labs$235K · 7 reports
- Pharmacy$6,667 · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES41 reports
- SENATE41 reports
- Health & Human Services, Dept of (HHS)13 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Food & Drug Administration (FDA)5 reports
- Executive Office of the President (EOP)3 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseOrchard Therapeutics North America | $2M | 8 quarters |
| S-3 Group | $470K | 7 quarters |
| The McManus Group | $380K | 6 quarters |
| LMH Strategic Solutions | $220K | 6 quarters |
| Corcoran & Associates, Inc. Dba Corcoran Partners | $150K | 5 quarters |
| Leavitt Partners | $110K | 5 quarters |
| Thegroup DC | $70K | 2 quarters |
| Cornerstone Government Affairs | $20K | 1 quarters |
| Jeffrey J. Kimbell & Associates | $20K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRETT MEEKS | Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander | Q2 2026 |
| CHANDA BETOURNEY | Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy | Q2 2026 |
| CHRISTOPHER BUKI | Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley | Q2 2026 |
| CONNOR SHEEHEY | Senate Finance: Senior Health Policy Advisor-Chair; Senior Health Policy Advisor-RM; Health Policy Advisor-RM; Deputy Legislative Director-Senate; Legislative Assistant-Senate; Deputy Legislative Assistant-Senate; Legislative Fellow-Senate | Q2 2026 |
| JOHN HERZOG | Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President | Q2 2026 |
| JOHN R RAY | Legislative Assistant, Rep. Mike Kelly | Q2 2026 |
| JOSH TRENT | Chief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential Personnel | Q2 2026 |
| KEITH STUDDARD | Legislative Director, Rep. Marsha Blackburn | Q2 2026 |
| KRISTIN FRITSCH | Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce | Q2 2026 |
| LAURA KEMPER | Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services | Q2 2026 |
| MARTIN DELGADO | Staff Dir, House Ag Approps, MilCon/VA Approps; Prof Staff, House Ag Approps, Senate Interior Approps; Budget Analysis, USDA APHIS | Q2 2026 |
| MARTIN REISER | Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee | Q2 2026 |
| MELISSA PFAFF | Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate | Q2 2026 |
| MICHAELEEN EARLE CROWELL | Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders | Q2 2026 |
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q2 2025 |
| JOHN MCMANUS | Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas | Q1 2024 |
| ALANNA TEMME | LD, Rep. Jon Porter | Q4 2023 |
| KARYN RICHMAN | Program Examiner, Executive Office of the President, Office of Management and Budget; Professional Staff, House Appropriations Committee | Q4 2022 |
| MARK MIODUSKI | Prof Staff; House Approps Cmte (Obey) | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Jeffrey J. Kimbell & Associates | $10K |
| 07/17for Q2 | S-3 Group | $60K |
| 07/17for Q2 | In-house | $190K |
| 07/16for Q2 | Corcoran & Associates, Inc. Dba Corcoran Partners | $30K |
| 07/15for Q2 | Leavitt Partners | $20K |
| 04/29for Q1 | In-house | $470K |
| 04/20for Q1 | Jeffrey J. Kimbell & Associates | $10K |
| 04/20for Q1 | Leavitt Partners | $30K |
| 04/20for Q1 | Corcoran & Associates, Inc. Dba Corcoran Partners | $30K |
| 04/17for Q1 | In-house | $350K |
| 04/17for Q1 | S-3 Group | $60K |
| 03/13for Q2 2025 | In-house | $430K |
| 02/13for Q1 | Jeffrey J. Kimbell & Associates | Under $5,000 |
| 01/20for Q4 2025 | Thegroup DC | $50K |
| 01/20for Q4 2025 | In-house | $260K |
| 01/16for Q4 2025 | Corcoran & Associates, Inc. Dba Corcoran Partners | $30K |
| 01/15for Q4 2025 | S-3 Group | $80K |
| 01/12for Q4 2025 | Leavitt Partners | $20K |
| 25/10/20for Q3 2025 | Thegroup DC | $20K |
| 25/10/20for Q3 2025 | Leavitt Partners | $20K |